This Three-Year Collaboration Aims to Deliver Scalable Health Solutions for Improved Disease Management. The Initiative Hopes to Benefit Patients Particularly in Remote or Underserved Regions with Limited Access to Care.
Researchers at the Max Delbrück Center and Aarhus University have found a mechanism through which the gene variant APOE4, long linked to a high risk of developing Alzheimer’s disease, impairs neuronal function in the aging brain. The research was…
Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In “Cardiovascular Research,” his group and a US team showed the therapy improves…
KNAUER Wissenschaftliche Geräte GmbH, based in Berlin, has announced the acquisition of Labomatic AG, located in Möhlin near Basel, Switzerland. With this strategic move, KNAUER significantly expands its leadership in preparative high-performance…
Collaboration for harmonized standards, improved networking, and continuing education in rheumatological laboratory diagnostics
As age increases, the pancreas changes, which increases the risk of metabolic diseases such as type 2 diabetes, digestive disorders, and also cancer. Researchers at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) have now been able…
IAVI, a nonprofit scientific research organization, based in New York, U.S.; Minapharm, the largest biosimilars manufacturer in Africa, based in Cairo, Egypt; and ProBioGen, a recognized leader in contract development and manufacturing, and a trusted…
U.K.-based Wellcome has awarded over €2 million to an international research effort to uncover how malaria can injure developing babies. Emanuel Wyler at the Max Delbrück Center will play a key role in studying the molecular interaction between the…
Apply until October 27, 2025
Study in Science: Researchers map correlations between gene variants and proteomes
